Up-regulation of Annexin-A1 and lipoxin A4 in individuals with ulcerative colitis may promote mucosal homeostasis

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Vong, Linda ^a   Ferraz, Jose G P ^c   Dufton, Neil ^b   Panaccione, Remo ^c   Beck, Paul L ^c   Sherman, Philip M ^a   Perretti, Mauro ^d   Wallace, John L ^b  

^a HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c UNIVERSITY OF CALGARY   (Canada)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FORMYL PEPTIDE RECEPTOR 2; FORMYLPEPTIDE RECEPTOR; GAMMA INTERFERON; INTERLEUKIN 1BETA; LIPOCORTIN 1; LIPOXIN A; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BIOCHEMISTRY; CELL INFILTRATION; CELL PROLIFERATION; CLINICAL ARTICLE; COLON BIOPSY; CONTROLLED STUDY; FEMALE; FLUORESCENCE MICROSCOPY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; INTESTINE CRYPT; LAMINA PROPRIA; LIPOGENESIS; MACROPHAGE MIGRATION; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LIPID INTERACTION; REMISSION; ULCERATIVE COLITIS; UPREGULATION;

ADULT; ANNEXIN A1; COLITIS, ULCERATIVE; COLON; CYCLOOXYGENASE 2; CYTOKINES; FEMALE; GRANULOCYTES; HOMEOSTASIS; HUMANS; INFLAMMATION MEDIATORS; INTESTINAL MUCOSA; LIPOXINS; MACROPHAGES; MALE; MIDDLE AGED; RECEPTORS, FORMYL PEPTIDE; RECEPTORS, LIPOXIN; UP-REGULATION;

EID: 84862502014     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039244     Document Type: Article

References (77)

1. Xavier RJ, Podolsky DK, (2007) Unravelling the pathogenesis of inflammatory bowel disease. Nature 448: 427-434.
2. Grisham MB, (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344: 859-861.
3. Nusrat A, Parkos CA, Liang TW, Carnes DK, Madara JL, (1997) Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113: 1489-1500.
4. Levy BD, Clish CB, Schmidt B, Gronert K, Serhan CN, (2001) Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2: 612-619.
5. Spite M, Norling LV, Summers L, Yang R, Cooper D, et al. (2009) Resolvin D2 is a potent regulator of leukocytes and controls microbial sepsis. Nature 461: 1287-1291.
6. Serhan CN, Savill J, (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197.
7. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, et al. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181: 5035-5044.
8. Rajakariar R, Hilliard M, Lawrence T, Trivedi S, Colville-Nash P, et al. (2007) Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyDelta12 14 PGJ2. Proc Natl Acad Sci U S A 104: 20979-20984.
9. Flower RJ, Rothwell NJ, (1994) Lipocortin-1: cellular mechanisms and clinical relevance. Trends Pharmacol Sci 15: 71-76.
10. Chatterjee BE, Yona S, Rosignoli G, Young RE, Nourshargh S, et al. (2005) Annexin 1-deficient neutrophils exhibit enhanced transmigration in vivo and increased responsiveness in vitro. J Leukoc Biol 78: 639-646.
11. Mancuso F, Flower RJ, Perretti M, (1995) Leukocyte transmigration, but not rolling or adhesion, is selectively inhibited by dexamethasone in the hamster post-capillary venule. Involvement of endogenous lipocortin 1. J Immunol 155: 377-386.
12. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, et al. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181: 5035-5044.
13. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, et al. (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281: 19588-19599.
14. Fiore S, Serhan CN, (1990) Formation of lipoxins and leukotrienes during receptor-mediated interactions of human platelets and recombinant human granulocyte/macrophage colony-stimulating factor-primed neutrophils. J Exp Med 172: 1451-1457.
15. Serhan CN, Sheppard KA, (1990) Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 85: 772-780.
16. Bandeira-Melo C, Bozza PT, Diaz BL, Cordeiro RS, Jose PJ, et al. (2000) Cutting edge: lipoxin (LX) A4 and aspirin-triggered 15-epi-LXA4 block allergen-induced eosinophil trafficking. J Immunol 164: 2267-2271.
17. Clish CB, Gronert K, Serhan CN, (2000) Local and systemic delivery of an aspirin-triggered lipoxin stable analog inhibits neutrophil trafficking. Ann N Y Acad Sci 905: 274-278.
18. Godson C, Mitchell S, Harvey K, Petasis NA, Hogg N, et al. (2000) Cutting edge: lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J Immunol 164: 1663-1667.
19. Maddox JF, Serhan CN, (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183: 137-146.
20. Maddox JF, Serhan CN, (1996) Lipoxin A4 and B4 are potent stimuli for human monocyte migration and adhesion: selective inactivation by dehydrogenation and reduction. J Exp Med 183: 137-146.
21. Mitchell S, Thomas G, Harvey K, Cottell D, Reville K, et al. (2002) Lipoxins, aspirin-triggered epi-lipoxins, lipoxin stable analogues, and the resolution of inflammation: stimulation of macrophage phagocytosis of apoptotic neutrophils in vivo. J Am Soc Nephrol 13: 2497-2507.
22. Colgan SP, Serhan CN, Parkos CA, Delp-Archer C, Madara JL, (1993) Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 92: 75-82.
23. Goh J, Baird AW, O'Keane C, Watson RW, Cottell D, et al. (2001) Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J Immunol 167: 2772-2780.
24. Gewirtz AT, McCormick B, Neish AS, Petasis NA, Gronert K, et al. (1998) Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs. J Clin Invest 101: 1860-1869.
25. Gronert K, Gewirtz A, Madara JL, Serhan CN, (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med 187: 1285-1294.
26. Perretti M, Chiang N, La M, Fierro IM, Marullo S, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 1296-1302.
27. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, et al. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181: 5035-5044.
28. Gastardelo TS, Damazo AS, Dalli J, Flower RJ, Perretti M, et al. (2009) Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol 174: 177-183.
29. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M, (2003) Leukocyte antiadhesive actions of annexin 1. Blood 101: 4140-4147.
30. Martin GR, Perretti M, Flower RJ, Wallace JL, (2008) Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol 294: G764-G769.
31. Croxtall JD, Waheed S, Choudhury Q, Anand R, Flower RJ, (1993) N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation. Int J Cancer 54: 153-158.
32. Croxtall JD, Choudhury Q, Flower RJ, (1998) Inhibitory effect of peptides derived from the N-terminus of lipocortin 1 on arachidonic acid release and proliferation in the A549 cell line: identification of E-Q-E-Y-V as a crucial component. Br J Pharmacol 123: 975-983.
33. Pederzoli-Ribeil M, Maione F, Cooper D, Al Kashi A, Dalli J, et al. (2010) Design and characterization of a cleavage-resistant Annexin A1 mutant to control inflammation in the microvasculature. Blood 116: 4288-4296.
34. Serhan CN, Savill J, (2005) Resolution of inflammation: the beginning programs the end. Nat Immunol 6: 1191-1197.
35. Grisham MB, (1994) Oxidants and free radicals in inflammatory bowel disease. Lancet 344: 859-861.
36. Nusrat A, Parkos CA, Liang TW, Carnes DK, Madara JL, (1997) Neutrophil migration across model intestinal epithelia: monolayer disruption and subsequent events in epithelial repair. Gastroenterology 113: 1489-1500.
37. Rugtveit J, Nilsen EM, Bakka A, Carlsen H, Brandtzaeg P, et al. (1997) Cytokine profiles differ in newly recruited and resident subsets of mucosal macrophages from inflammatory bowel disease. Gastroenterology 112: 1493-1505.
38. Rugtveit J, Haraldsen G, Hogasen AK, Bakka A, Brandtzaeg P, et al. (1995) Respiratory burst of intestinal macrophages in inflammatory bowel disease is mainly caused by CD14+L1+ monocyte derived cells. Gut 37: 367-373.
39. Bystrom J, Evans I, Newson J, Stables M, Toor I, et al. (2008) Resolution-phase macrophages possess a unique inflammatory phenotype that is controlled by cAMP. Blood 112: 4117-4127.
40. Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL, (2010) A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci U S A 107: 12023-12027.
41. Colgan SP, Serhan CN, Parkos CA, Delp-Archer C, Madara JL, (1993) Lipoxin A4 modulates transmigration of human neutrophils across intestinal epithelial monolayers. J Clin Invest 92: 75-82.
42. Goh J, Baird AW, O'Keane C, Watson RW, Cottell D, et al. (2001) Lipoxin A(4) and aspirin-triggered 15-epi-lipoxin A(4) antagonize TNF-alpha-stimulated neutrophil-enterocyte interactions in vitro and attenuate TNF-alpha-induced chemokine release and colonocyte apoptosis in human intestinal mucosa ex vivo. J Immunol 167: 2772-2780.
43. Fiorucci S, Wallace JL, Mencarelli A, Distrutti E, Rizzo G, et al. (2004) A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction. Proc Natl Acad Sci U S A 101: 15736-15741.
44. Gewirtz AT, Collier-Hyams LS, Young AN, Kucharzik T, Guilford WJ, et al. (2002) Lipoxin a4 analogs attenuate induction of intestinal epithelial proinflammatory gene expression and reduce the severity of dextran sodium sulfate-induced colitis. J Immunol 168: 5260-5267.
45. Lee TH, Crea AE, Gant V, Spur BW, Marron BE, et al. (1990) Identification of lipoxin A4 and its relationship to the sulfidopeptide leukotrienes C4, D4, and E4 in the bronchoalveolar lavage fluids obtained from patients with selected pulmonary diseases. Am Rev Respir Dis 141: 1453-1458.
46. Pouliot M, Clish CB, Petasis NA, Van Dyke TE, Serhan CN, (2000) Lipoxin A(4) analogues inhibit leukocyte recruitment to Porphyromonas gingivalis: a role for cyclooxygenase-2 and lipoxins in periodontal disease. Biochemistry 39: 4761-4768.
47. Edenius C, Kumlin M, Bjork T, Anggard A, Lindgren JA, (1990) Lipoxin formation in human nasal polyps and bronchial tissue. FEBS Lett 272: 25-28.
48. Jupp J, Hillier K, Elliott DH, Fine DR, Bateman AC, et al. (2007) Colonic expression of leukotriene-pathway enzymes in inflammatory bowel diseases. Inflamm Bowel Dis 13: 537-546.
49. Perretti M, Chiang N, La M, Fierro IM, Marullo S, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 1296-1302.
50. Souza DG, Fagundes CT, Amaral FA, Cisalpino D, Sousa LP, et al. (2007) The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol 179: 8533-8543.
51. Brancaleone V, Dalli J, Bena S, Flower RJ, Cirino G, et al. (2011) Evidence for an Anti-Inflammatory Loop Centered on Polymorphonuclear Leukocyte Formyl Peptide Receptor 2/Lipoxin A4 Receptor and Operative in the Inflamed Microvasculature. J Immunol.
52. Vergnolle N, Pages P, Guimbaud R, Chaussade S, Bueno L, et al. (2004) Annexin 1 is secreted in situ during ulcerative colitis in humans. Inflamm Bowel Dis 10: 584-592.
53. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, et al. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181: 5035-5044.
54. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, et al. (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281: 19588-19599.
55. Martin GR, Perretti M, Flower RJ, Wallace JL, (2008) Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol 294: G764-G769.
56. Babbin BA, Laukoetter MG, Nava P, Koch S, Lee WY, et al. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J Immunol 181: 5035-5044.
57. Vong L, D'Acquisto F, Pederzoli-Ribeil M, Lavagno L, Flower RJ, et al. (2007) Annexin 1 cleavage in activated neutrophils: a pivotal role for proteinase 3. J Biol Chem 282: 29998-30004.
58. Duncan R, Carpenter B, Main LC, Telfer C, Murray GI, (2008) Characterisation and protein expression profiling of annexins in colorectal cancer. Br J Cancer 98: 426-433.
59. Jiang D, Ying W, Lu Y, Wan J, Zhai Y, et al. (2003) Identification of metastasis-associated proteins by proteomic analysis and functional exploration of interleukin-18 in metastasis. Proteomics 3: 724-737.
60. Xin W, Rhodes DR, Ingold C, Chinnaiyan AM, Rubin MA, (2003) Dysregulation of the annexin family protein family is associated with prostate cancer progression. Am J Pathol 162: 255-261.
61. Perretti M, Chiang N, La M, Fierro IM, Marullo S, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 1296-1302.
62. Ye RD, Boulay F, Wang JM, Dahlgren C, Gerard C, et al. (2009) International Union of Basic and Clinical Pharmacology. LXXIII. Nomenclature for the formyl peptide receptor (FPR) family. Pharmacol Rev 61: 119-161.
63. Le Y, Murphy PM, Wang JM, (2002) Formyl-peptide receptors revisited. Trends Immunol 23: 541-548.
64. Babbin BA, Lee WY, Parkos CA, Winfree LM, Akyildiz A, et al. (2006) Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors. J Biol Chem 281: 19588-19599.
65. der Weid PY, Hollenberg MD, Fiorucci S, Wallace JL, (2004) Aspirin-triggered, cyclooxygenase-2-dependent lipoxin synthesis modulates vascular tone. Circulation 110: 1320-1325.
66. Gastardelo TS, Damazo AS, Dalli J, Flower RJ, Perretti M, et al. (2009) Functional and ultrastructural analysis of annexin A1 and its receptor in extravasating neutrophils during acute inflammation. Am J Pathol 174: 177-183.
67. Gavins FN, Yona S, Kamal AM, Flower RJ, Perretti M, (2003) Leukocyte antiadhesive actions of annexin 1. Blood 101: 4140-4147.
68. Martin GR, Perretti M, Flower RJ, Wallace JL, (2008) Annexin-1 modulates repair of gastric mucosal injury. Am J Physiol Gastrointest Liver Physiol 294: G764-G769.
69. Scannell M, Flanagan MB, deStefani A, Wynne KJ, Cagney G, et al. (2007) Annexin-1 and peptide derivatives are released by apoptotic cells and stimulate phagocytosis of apoptotic neutrophils by macrophages. J Immunol 178: 4595-4605.
70. Souza DG, Fagundes CT, Amaral FA, Cisalpino D, Sousa LP, et al. (2007) The required role of endogenously produced lipoxin A4 and annexin-1 for the production of IL-10 and inflammatory hyporesponsiveness in mice. J Immunol 179: 8533-8543.
71. Dufton N, Hannon R, Brancaleone V, Dalli J, Patel HB, et al. (2010) Anti-inflammatory role of the murine formyl-peptide receptor 2: ligand-specific effects on leukocyte responses and experimental inflammation. J Immunol 184: 2611-2619.
72. Gronert K, Gewirtz A, Madara JL, Serhan CN, (1998) Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J Exp Med 187: 1285-1294.
73. Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL, (2010) A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci U S A 107: 12023-12027.
74. Chavez-Pina AE, Vong L, McKnight W, Dicay M, Zanardo RC, et al. (2008) Lack of effects of acemetacin on signalling pathways for leukocyte adherence may explain its gastrointestinal safety. Br J Pharmacol 155: 857-864.
75. Vong L, Ferraz JG, Panaccione R, Beck PL, Wallace JL, (2010) A pro-resolution mediator, prostaglandin D(2), is specifically up-regulated in individuals in long-term remission from ulcerative colitis. Proc Natl Acad Sci U S A 107: 12023-12027.
76. Perretti M, Chiang N, La M, Fierro IM, Marullo S, et al. (2002) Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor. Nat Med 8: 1296-1302.
77. Souza MH, de Lima OM Jr, Zamuner SR, Fiorucci S, Wallace JL, (2003) Gastritis increases resistance to aspirin-induced mucosal injury via COX-2-mediated lipoxin synthesis. Am J Physiol Gastrointest Liver Physiol 285: G54-G61.